Infotonics Technology Center and BioScopix Inc. a Delaware "Spin-Off" subsidiary of Cherry Hill New Jersey-based Mediscience Technology Corp. (MTC), (OTCBB:MDSC), a developer of proprietary non-invasive imaging technology for molecular detection of cancer and physiological change, announced Dr. Laura Weller-Brophy as Biomedical Product Development and Commercialization Manager.
Dr. Brophy will focus her efforts on bringing to market optical diagnostic products being developed by Mediscience "Spin-Off" subsidiary BioScopix, Inc., in collaboration with equity partner Infotonics.
MTC-BioScopix Inc. and Infotonics initiatives include a CD-Ratiometer and an Optical Biopsy Pill, both designed to detect cancer within a patient's body, without surgery or dyes, through MTC propriatery technology based on optical spectroscopy.
"Laura has extensive experience in the field of optics," said Infotonics CEO David R. Smith. "Her appointment is a key step as we expand our research and development and commercialization efforts in identified biomedical markets."
Dr. Weller-Brophy, who holds bachelor's, master's, and doctoral degrees in Optics from the University of Rochester, most recently held the title of intellectual property and business strategist, optical display films, at Eastman Kodak Company. In addition to four years as an optical scientist at Kodak, her experience includes research and management positions at Corning, Inc., and 3M. She is the author or co-author of some 20 scientific papers and publications, and is listed as a holder of 22 United States patents.
Mediscience Chairman Peter Katevatis Esq. stated, "Dr. Brophy's hands-on presence is expected to enhance and accelerate MTC's ability to commercialize our patented Optical Biopsy technology platform."
About the Infotonics Center
The Infotonics Technology Center Inc. (Infotonics) is a not-for-profit corporation that operates New York State's Center of Excellence in Photonics and Microsystems. Infotonics is structured as a consortium whose founding participants include Corning, Inc., Eastman Kodak Company, and Xerox Corporation. Academic participants include some 20 New York State colleges and universities. Infotonics' goal is to establish a unique, world-class research and development facility to enable rapid commercialization of new products. This initiative will provide major benefits to the region, including creation of jobs and attraction of new companies and investment revenue.
INVESTOR NOTICE: Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the parties/ company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include among other things, the availability of financing, the parties/ company's ability to implement its long-range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary US regulatory clearances applicable to applications of the company' technology; and management of growth and other risked and uncertainties that may be detailed from time to time in the parties/ company's reports filed with the Securities and Exchange Commission. This disclosure is intended to satisfy: SEC Section 6, 6.01 Regulation FD, disclosure and Section 7 and 7.0 as well as all applicable and presently effective Sarbanes-Oxley disclosure requirements under Regulation G.
See Web sites:
www.infotonics.org/ResearchProjects/CompactPhotonicExplorers.asp
www.cunyphotonics.com
www.MEDISCIENCETECH.com
Mediscience 8-K filing dated Dec. 15, 2006 Empire Financial Group, Inc. Financing Agreement
CITIGROUP/Smith Barney Analyst Report 10-1-2004 by Peter Bye. Page 20 Registrant-Infotonics
8-K filing May 24, 2006 72 Pg Syracuse University Report
